| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Aashit Shah | Q40950500 |
| Yoshiki Arakawa | Q48669000 | ||
| Lisa M DeAngelis | Q53760126 | ||
| Martin J van den Bent | Q61372103 | ||
| Terri S Armstrong | Q78731158 | ||
| Jaap C Reijneveld | Q93118855 | ||
| Patrick Y Wen | Q105531697 | ||
| P2093 | author name string | Michael Weller | |
| Johan A F Koekkoek | |||
| Jorge Gonzalez-Martinez | |||
| David Schiff | |||
| Marc Chamberlain | |||
| Ryo Nishikawa | |||
| Sandeep Mittal | |||
| Ali Choucair | |||
| Charles J Vecht | |||
| Edward K Avila | |||
| Paula Warren | |||
| David R MacDonald | |||
| Roberta Ruda | |||
| P2860 | cites work | Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review | Q27027730 |
| Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy | Q28243859 | ||
| Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009 | Q28274778 | ||
| Efficacy of intraoperative electrocorticography for assessing seizure outcomes in intractable epilepsy patients with temporal-lobe-mass lesions | Q28278059 | ||
| Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas | Q30452695 | ||
| Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial | Q33223508 | ||
| Epilepsy and brain tumors: implications for treatment | Q33788361 | ||
| Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. | Q33865523 | ||
| Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components | Q34156372 | ||
| National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods | Q34174655 | ||
| Sudden unexpected death in epilepsy: addressing the challenges | Q34317703 | ||
| Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study | Q34528797 | ||
| Reproductive dysfunction in women with epilepsy | Q35540890 | ||
| Neurocognitive sequelae in the treatment of low-grade gliomas | Q35650079 | ||
| Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. | Q35696397 | ||
| Tracking psychosocial health in adults with epilepsy--estimates from the 2010 National Health Interview Survey | Q36041543 | ||
| Long-term seizure outcome following surgery for dysembryoplastic neuroepithelial tumor | Q36410245 | ||
| Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide | Q36480099 | ||
| Seizure severity in children with epilepsy: a parent-completed scale compared with clinical data | Q36850380 | ||
| Seizure characteristics and control following resection in 332 patients with low-grade gliomas | Q37074101 | ||
| Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study | Q37312684 | ||
| Measuring outcomes of treatment with antiepileptic drugs in clinical trials | Q37750042 | ||
| Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. | Q37870185 | ||
| Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients | Q38244843 | ||
| Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis | Q38262056 | ||
| Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. | Q38450013 | ||
| Weight of epilepsy in brain tumor patients. | Q39199891 | ||
| Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL. | Q40774694 | ||
| Alternate endpoints for seizure measurement. | Q41668225 | ||
| Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas | Q44663935 | ||
| Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response | Q44663938 | ||
| Effect of epilepsy and antiepileptic drugs on male reproductive health | Q44743460 | ||
| Epilepsy: accuracy of patient seizure counts | Q45069025 | ||
| Epileptogenic cerebral low-grade tumors: effect of interstitial stereotactic irradiation on seizures | Q45883668 | ||
| The effect of recurrent seizures on cognitive, behavioral, and quality-of-life outcomes after 12 months of monotherapy in adults with newly diagnosed or previously untreated partial epilepsy | Q46293583 | ||
| Everolimus treatment of refractory epilepsy in tuberous sclerosis complex | Q46921350 | ||
| Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory | Q47762611 | ||
| Fractionated stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and prognostic factors | Q48163842 | ||
| Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy | Q48238622 | ||
| PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. | Q48359025 | ||
| Gamma-Knife radiosurgery of mesiotemporal tumour epilepsy observations and long-term results | Q48469018 | ||
| Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life | Q48624627 | ||
| Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide | Q48641340 | ||
| IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom | Q48729040 | ||
| Health-related quality of life and seizure control in temporal lobe epilepsy | Q48742400 | ||
| Intracranial EEG analysis in tumor-related epilepsy: Evidence of distant epileptic abnormalities. | Q51675660 | ||
| Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life | Q51946497 | ||
| Consistency of seizure frequency estimates across time, methods, and observers. | Q52111746 | ||
| The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. | Q52304792 | ||
| Patient-validated content of epilepsy-specific quality-of-life measurement. | Q52892849 | ||
| Very good inter-rater reliability of Engel and ILAE epilepsy surgery outcome classifications in a series of 76 patients. | Q53088985 | ||
| Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. | Q53976387 | ||
| Radiological and clinical outcome following stereotactic biopsy and radiotherapy for low-grade insular astrocytomas. | Q55472378 | ||
| Low-grade oligodendroglioma responds to chemotherapy. | Q55480129 | ||
| The development of a seizure severity scale as an outcome measure in epilepsy | Q67940149 | ||
| Reliability of seizure diaries in adult epileptic patients | Q69793016 | ||
| A method of quantification for the evaluation of antiepileptic drug therapy | Q71228494 | ||
| ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery | Q73590962 | ||
| Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients | Q77297922 | ||
| What is New in the Management of Epilepsy in Gliomas? | Q87186237 | ||
| P433 | issue | 1 | |
| P921 | main subject | seizure | Q6279182 |
| P304 | page(s) | 12-21 | |
| P577 | publication date | 2016-09-20 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials | |
| P478 | volume | 19 |
| Q88990486 | Choice of antiepileptic drugs affects the outcome in cancer patients with seizures |
| Q90296566 | Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 |
| Q39320307 | End of life care for glioblastoma patients at a large academic cancer center. |
| Q49362877 | How bad are your seizures and did the treatment help? |
| Q47419073 | IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy. |
| Q48187820 | Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. |
| Q48295109 | Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics. |
| Q89489899 | Molecular Aberrations Associated with Seizure Control in Diffuse Astrocytic and Oligodendroglial Tumors |
| Q90643353 | Primary brain tumours in adults |
| Q38695438 | Rates of Seizure Freedom after Surgical Resection of Diffuse Low-Grade Gliomas |
| Q45945655 | Response Assessment in Neuro-Oncology Clinical Trials. |
| Q92446516 | Seizure burden pre- and postresection of low-grade gliomas as a predictor of tumor progression in low-grade gliomas |
| Q53242313 | Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials-impact of psychogenic non-epileptic seizures. |
| Q91901434 | Seizure response to temozolomide chemotherapy in patients with WHO grade II oligodendroglioma: a single-institution descriptive study |
| Q64114259 | The surgical perspective in precision treatment of diffuse gliomas |
| Q47235768 | The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy |
| Q64099817 | Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice |
| Q64234109 | Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study |
Search more.